Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Business Environment / Turkey

Deva Holding To Re-Focus On Developed Markets

June 2009 | Industry Trend Analysis

To read the full article, please choose one of the following options:

Subcribers please log in

Turkish pharmaceutical company Deva Holding plans to redirect its export strategy towards the developed markets of Western Europe and the US, according to Chairman Philipp Haas. Deva Holding's strategy sees the company orient itself towards more stable operating environments, which Haas believes to be potentially 'more rewarding' than emerging markets 'that are more risky and tend to have payment problems'. BMI notes that while much of Big Pharma is gearing expansion towards emerging markets due to their high potential, priorities for smaller emerging market firms such as Deva Holding are often largely